CPMV Vector Start Codon Mutation for Protein Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current viral vector systems for expressing heterologous proteins in plants face challenges such as limited protein yield and ease of use, particularly due to constraints on sequence insertion length and maintenance of specific reading frames, which restricts the flexibility of cloning and can lead to plant health issues and protein purification complications.

Innovation Solution

Mutation of the start codon at position 161 in a CPMV RNA-2 vector increases protein expression levels 20-30 fold, allows for insertion of sequences of any length, and improves plant health by eliminating the need to maintain the reading frame between initiation sites, enabling the use of polylinkers and facilitating the cloning of foreign genes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the reading frame between initiation sites is maintained, then efficient viral replication is achieved, but the length of insertable sequences is restricted and cloning flexibility is reduced

Engineering Contradiction:
Improveviral replication efficiencyVSAvoidcloning flexibility
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent removes the constraint of maintaining a specific reading frame between initiation sites by deleting or mutating the first initiation site (AUG at position 161). This extraction of the reading frame requirement allows unlimited sequence insertion while preserving viral replication through alternative initiation mechanisms at downstream sites.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the parameter of initiation site configuration by introducing mutations or deletions at position 161, thereby altering the translation initiation pattern. This parameter change enables the system to tolerate variable sequence lengths and compositions without compromising replication efficiency, as ribosomes initiate at alternative downstream sites.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If polylinkers are used for cloning, then cloning flexibility is improved, but the reading frame between initiation sites is altered and expression efficiency decreases

Engineering Contradiction:
Improvecloning flexibilityVSAvoidprotein expression level
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent removes the reading frame constraint that normally prevents polylinker use by mutating or deleting the first initiation site. This extraction eliminates the conflict between polylinker insertion and reading frame maintenance, allowing polylinkers to be used freely without reducing expression efficiency, as translation initiates at downstream sites that are not affected by polylinker sequence composition.

Inventive Principle:
Principle #2Taking out (Extraction)

3Length of stationary object

If sequence insertion length is increased, then more foreign genes can be cloned, but the reading frame maintenance becomes more difficult and cloning complexity increases

Engineering Contradiction:
Improveinsertable sequence lengthVSAvoidcloning complexity
Core Design Contradiction:
Length of stationary objectVSDevice complexity

Solution Approach 1:

The invention extracts the reading frame maintenance requirement by mutating or deleting the first initiation site, thereby eliminating the need to calculate and preserve specific frame relationships. This allows sequences of any length to be inserted without increasing cloning complexity, as the system automatically initiates translation at downstream sites regardless of insert length or composition.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS10947549B2Protein expression systems
Publication Date: 2021.03.16 PLANT BIOSCIENCE LIMITED
  • US10947549B2 patent drawing
  • US10947549B2 patent drawing
  • US10947549B2 patent drawing

AI summary

The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.